Fortress Biotech
FBIO
79 hedge funds and large institutions have $97.5M invested in Fortress Biotech in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 14 closing their positions.
57% more call options, than puts
Call options by funds: $1.01M | Put options by funds: $642K
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
0.06% less ownership
Funds ownership: 2.06% → 2% (-0.06%)
6% less funds holding
Funds holding: 84 → 79 (-5)
9% less capital invested
Capital invested by funds: $107M → $97.5M (-$9.66M)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.99M |
| 2 |
Two Sigma Advisers
New York
|
+$388K |
| 3 |
TI
Telemetry Investments
New York
|
+$179K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$154K |
| 5 |
Goldman Sachs
New York
|
+$153K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$528K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$407K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$306K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$277K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$197K |
FBIO Hedge Fund Activity: Q3 2021 in Review
79 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2021, worth a combined $97.5M — down 9% from $107M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of FBIO and 9 opened new positions — a net loss of 5 holders — while 22 trimmed existing stakes and 28 added.
The largest buyer was Nantahala Capital Management, adding an estimated $1.99M. The largest seller was Russell Investments Group, cutting an estimated $528K.
- 79 institutional investors held Fortress Biotech (FBIO) as of Q3 2021, down from 84 in Q2 2021.
- Funds reported $97.5M of Fortress Biotech stock for Q3 2021, down 9% quarter-over-quarter.
- 9 funds opened new Fortress Biotech positions in Q3 2021 and 14 closed out, a net change of -5 holders.
- The largest Fortress Biotech buyer in Q3 2021 was Nantahala Capital Management, an estimated $1.99M added.
- The largest Fortress Biotech seller in Q3 2021 was Russell Investments Group, an estimated $528K sold.
Based on aggregated 13F filings for Q3 2021.